Dentistry and Medical Sciences
Dr Martin Pal is an expert in genome editing and CRISPR-technology and has extensive research experience across multiple disease backgrounds (metabolism, exercise, cancers including liver, breast, blood).
Dr Pal received his PhD in Genetics from the University of Cologne, Germany, and before joining Charles Sturt in 2021, Dr Pal performed postdoctoral research at four of Australia’s preeminent medical research institutes (WEHI, JCSMR, Garvan, Baker IDI.
Dr Pal’s research focusses on developing novel genetic models using CRISPR-technology (Pillar 2 of THRIIVE); discovery driven-work with CRISPR-technology for novel drug targets (Pillar 2 of THRIIVE); and developing novel detection methods for domestic zoonotic pathogens using CRISPR Diagnostics (ECR Grant, 2022) (Pillar 3 of THRIIVE). In addition, Dr Pal played a pivotal role in the generation of the recently launched online learning course “CRISPR 101", which utilises innovative online learning tools to foster community engagement (Pillar 4 of THRIIVE)
In collaboration with Prof Jade Forwood he is investigating mechanisms of nuclear import for both cancer-driving and tumour-suppressing genes with the aim of finding novel therapeutic avenues